Between 2017 and 2023, The structure has been and is currently involved in several international projects:

• PI for the INT of the European H2020 project entitled "Standardisation and improvement of generic pre-analytical tools and procedures for in vitro diagnostics for personalised medicine - SPIDIA4P" (www.spidia.eu, 01/01/2017 - 30/06/2021), focused on the drafting of CEN/ISO guidelines for the pre-analytical phase of the determination of genetic-molecular biomarkers in different biological matrices.
• Group Leader within the Accelerator Award project entitled 'Pseudomyxoma peritonei: building a European multicentric cohort to accelerate new therapeutic perspectives' (01/04/2020- 30/06/2025, PI: Dr. M. Deraco) (https://pmpnet.eu/). The ultimate goal of the project is the creation of a European database for a large number of patients with pseudomyxoma peritonei, which will allow better investigation of this rare disease.
• Collaborator within the TRANSCAN project "MICROTHER" (Improving immunotherapy of solid tumours by targeting the immunosuppressive tumour microenvironment: from pre-clinical "proof-of-concept" to the development of phase I studies, Eranet Transcan JTC 2015) (PI: Dr. M. di Nicola). The activity was focused to the design and statistical analysis of data from the project in relation to breast, colon and head-neck cancer;
• Statistician in Chief (from 2020) for projects related to the neo-ALTTO study on the evaluation of molecular biomarkers (project reference: "Gene expression profile to identify patients who benefit from HER2-targeted therapy", Neo-ALTTO Research Project ID: NM0408, PI: S. Di Cosimo). Within this project, the unit deals with the identification and validation of molecular signatures at both predictive and prognostic level in different biological matrices.
• and also in national projects funded by the AIRC Foundation as well as projects related to institutional research lines.